A Computational Model to Predict Rat Ovarian Steroid Secretion from In Vitro Experiments with Endocrine Disruptors

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Quignot, Nadia ^a,b   Bois, Frédéric Y ^a,b  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROSTENEDIONE; AROMATASE; ATRAZINE; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRONE; LETROZOLE; MESSENGER RNA; METHOXYCHLOR; SEX HORMONE; TESTOSTERONE; VINCLOZOLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ESTRUS CYCLE; FEMALE; GRANULOSA CELL; HORMONE RESPONSE; IN VITRO STUDY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; RAT; STEROID METABOLISM; STEROID RELEASE; STEROIDOGENESIS;

ANDROGENS; ANIMALS; AROMATASE; ENDOCRINE DISRUPTORS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; MODELS, THEORETICAL; OVARY; RATS; REPRODUCTION;

RATTUS;

EID: 84872246574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053891     Document Type: Article

References (54)

1. Maranghi F, Mantovani A, (2012) Targeted toxicological testing to investigate the role of endocrine disrupters in puberty disorders. Reprod Toxicol 33: 290-296.
2. Holloway AC, Anger DA, Crankshaw DJ, Wu M, Foster WG, (2008) Atrazine-induced changes in aromatase activity in estrogen sensitive target tissues. J Appl Toxicol 28: 260-270.
3. Fan W, Yanase T, Morinaga H, Gondo S, Okabe T, et al. (2007) Herbicide atrazine activates SF-1 by direct affinity and concomitant co-activators recruitments to induce aromatase expression via promoter II. Biochem Biophys Res Commun 355: 1012-1018.
4. Molina-Molina JM, Hillenweck A, Jouanin I, Zalko D, Cravedi JP, et al. (2006) Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol Appl Pharmacol 216: 44-54.
5. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE, (1994) Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126: 276-285.
6. Cummings AM, (1997) Methoxychlor as a model for environmental estrogens. Crit Rev Toxicol 27: 367-379.
7. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, et al. (2000) Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol 58: 852-858.
8. Hiroi H, Tsutsumi O, Momoeda M, Takai Y, Osuga Y, et al. (1999) Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta. Endocr J 46: 773-778.
9. Petkov PI, Temelkov S, Villeneuve DL, Ankley GT, Mekenyan OG, (2009) Mechanism-based categorization of aromatase inhibitors: a potential discovery and screening tool. SAR QSAR Environ Res 20: 657-678.
10. Odum J, Ashby J, (2002) Detection of aromatase inhibitors in vitro using rat ovary microsomes. Toxicol Lett 129: 119-122.
11. Sandhoff TW, McLean MP, (1996) Hormonal regulation of steroidogenic acute regulatory (StAR) protein messenger ribonucleic acid expression in the rat ovary. Endocrine 4: 259-267.
12. Lovekamp TN, Davis BJ, (2001) Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol Appl Pharmacol 172: 217-224.
13. EPA (2007) Integrated Summary Report on Aromatase. Environmental Protection Agency. Available: http://www.epa.gov/endo/pubs/aromatase_isr.pdf. Accessed 2012 August 27.
14. Stocco C, (2008) Aromatase expression in the ovary: hormonal and molecular regulation. Steroids 73: 473-487.
15. Akinola LA, Poutanen M, Vihko R, (1996) Cloning of rat 17 beta-hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes. Endocrinology 137: 1572-1579.
16. Stokes WS, (2004) Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies. Ilar J 45: 387-393.
17. Charles GD, (2004) In vitro models in endocrine disruptor screening. Ilar J 45: 494-501.
18. Holme JA, Dybing E, (2002) The use of in vitro methods for hazard characterisation of chemicals. Toxicol Lett 127: 135-141.
19. Wang C, Hsueh AJ, Erickson GF, (1981) LH stimulation of estrogen secretion by cultured rat granulosa cells. Mol Cell Endocrinol 24: 17-28.
20. Quignot N, Desmots S, Barouki R, Lemazurier E, (2012a) A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation. Toxicol In Vitro 26: 107-118.
21. Lephart ED, Simpson ER, McPhaul MJ, (1992) Ovarian aromatase cytochrome P-450 mRNA levels correlate with enzyme activity and serum estradiol levels in anestrous, pregnant and lactating rats. Mol Cell Endocrinol 85: 205-214.
22. Goldman JM, Murr AS, Cooper RL, (2007) The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 80: 84-97.
23. Quignot N, Tournier M, Pouech C, Cren-Olive C, Barouki R, et al. (2012b) Quantification of steroids and endocrine disrupting chemicals in rat ovaries by LC-MS/MS for reproductive toxicology assessment. Anal Bioanal Chem 403: 1629-1640.
24. Sinha S, Kaseta J, Santner SJ, Demers LM, Bremmer WJ, et al. (1998) Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat. Breast Cancer Res Treat 48: 45-51.
25. Zheng X, Price CA, Tremblay Y, Lussier JG, Carriere PD, (2008) Role of transforming growth factor-beta1 in gene expression and activity of estradiol and progesterone-generating enzymes in FSH-stimulated bovine granulosa cells. Reproduction 136: 447-457.
26. Breen MS, Breen M, Terasaki N, Yamazaki M, Conolly RB, (2009) Computational model of steroidogenesis in human H295R cells to predict biochemical response to endocrine-active chemicals: model development for metyrapone. Environ Health Perspect 118: 265-272.
27. Quignot N, Arnaud M, Robidel F, Lecomte A, Tournier M, et al. (2012c) Characterization of endocrine-disrupting chemicals based on hormonal balance disruption in male and female adult rats. Reprod Toxicol 33: 339-352.
28. Bois FY, (2009) GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models. Bioinformatics 25: 1453-1454.
29. Gelman A, Rubin DB, (1992) Inference from Iterative Simulation Using Multiple Sequences (with Discussion). Statistical Sciences 7: 457-511.
30. Liebermeister W, Klipp E, (2005) Biochemical networks with uncertain parameters. Syst Biol (Stevenage) 152: 97-107.
31. Massey FJ, (1951) The Kolmogorov-Smirnov test for goodness of fit. J Amer Statistical Assoc 46: 68-78.
32. Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, et al. (2008) CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proceedings of the IEEE 96: 1254-1265.
33. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, http://www.R-project.org/.
34. Gordon A, Garrido-Gracia JC, Aguilar R, Guil-Luna S, Millan Y, et al. (2009) Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat. Reproduction 137: 151-159.
35. Andersen ME, Thomas RS, Gaido KW, Conolly RB, (2005) Dose-response modeling in reproductive toxicology in the systems biology era. Reprod Toxicol 19: 327-337.
36. Villeneuve DL, Larkin P, Knoebl I, Miracle AL, Kahl MD, et al. (2007) A graphical systems model to facilitate hypothesis-driven ecotoxicogenomics research on the teleost brain-pituitary-gonadal axis. Environ Sci Technol 41: 321-330.
37. Villeneuve DL, Garcia-Reyero N, Martinovic-Weigelt D, Li Z, Watanabe KH, et al. (2012) A graphical systems model and tissue-specific functional gene sets to aid transcriptomic analysis of chemical impacts on the female teleost reproductive axis. Mutat Res 746: 151-162.
38. Breen MS, Villeneuve DL, Breen M, Ankley GT, Conolly RB, (2007) Mechanistic computational model of ovarian steroidogenesis to predict biochemical responses to endocrine active compounds. Ann Biomed Eng 35: 970-981.
39. Watanabe KH, Li Z, Kroll KJ, Villeneuve DL, Garcia-Reyero N, et al. (2009) A computational model of the hypothalamic-pituitary-gonadal axis in male fathead minnows exposed to 17alpha-ethinylestradiol and 17beta-estradiol. Toxicol Sci 109: 180-192.
40. Li Z, Kroll KJ, Jensen KM, Villeneuve DL, Ankley GT, et al. (2011) A computational model of the hypothalamic: pituitary: gonadal axis in female fathead minnows (Pimephales promelas) exposed to 17alpha-ethynylestradiol and 17beta-trenbolone. BMC Syst Biol 5: 63.
41. Soffker M, Tyler CR, (2012) Endocrine disrupting chemicals and sexual behaviors in fish- a critical review on effects and possible consequences. Crit Rev Toxicol 42: 653-668.
42. Fang H, Tong W, Shi LM, Blair R, Perkins R, et al. (2001) Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol 14: 280-294.
43. Andersen ME, Clewell HJ, 3rd, Gearhart J, Allen BC, Barton HA (1997) Pharmacodynamic model of the rat estrus cycle in relation to endocrine disruptors. J Toxicol Environ Health 52: 189-209.
44. Bertram R, Li YX, (2008) A mathematical model for the actions of activin, inhibin, and follistatin on pituitary gonadotrophs. Bull Math Biol 70: 2211-2228.
45. Harada N, Honda SI, Hatano O, (1999) Aromatase inhibitors and enzyme stability. Endocr Relat Cancer 6: 211-218.
46. Auvray P, Nativelle C, Bureau R, Dallemagne P, Seralini GE, et al. (2002) Study of substrate specificity of human aromatase by site directed mutagenesis. Eur J Biochem 269: 1393-1405.
47. Hargrove JL, Hulsey MG, Summers AO, (1993a) From genotype to phenotype: computer-based modeling of gene expression with STELLA II. Biotechniques 15: 1096-1101.
48. Hargrove JL, (1993b) Microcomputer-assisted kinetic modeling of mammalian gene expression. Faseb J 7: 1163-1170.
49. Renwick AG, Soon CY, Chambers SM, Brown CR, (1981) Estradiol-17 beta dehydrogenase from chicken liver. J Biol Chem 256: 1881-1887.
50. Plowchalk DR, Teeguarden J, (2002) Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: a biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds. Toxicol Sci 69: 60-78.
51. Odum J, Tinwell H, Van Miller J, Joiner R, Ashby J, (2001) The uterotrophic activity of nonylphenol in the rat is not mediated by aromatase enzyme induction. Toxicol Lett 118: 165-169.
52. Krekels MD, Wouters W, De Coster R, (1990) Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates. Steroids 55: 69-73.
53. Ishikura S, Matsumoto K, Sanai M, Horie K, Matsunaga T, et al. (2006) Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme. J Biochem 139: 1053-1063.
54. Steckelbroeck S, Watzka M, Reissinger A, Wegener-Toper P, Bidlingmaier F, et al. (2003) Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain. J Steroid Biochem Mol Biol 86: 79-92.